Form 4: Director Shirley Weis Receives Pediatrix Equity Grant

Director Shirley A. Weis was granted 7,196 restricted shares of Pediatrix Medical Group, Inc. as part of an annual equity award.

Summary

• Director Shirley A. Weis acquired 7,196 restricted shares of Pediatrix Medical Group, Inc. (MD) common stock.
• The shares were granted on May 7, 2026, under the company's Amended and Restated 2008 Incentive Compensation Plan.
• The grant is part of an annual equity award program for directors.
• Following this transaction, the director's direct beneficial ownership increased to 18,623 shares.
• The director also maintains an indirect interest in 36,028 shares held by The Weis Family Trust.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a routine administrative filing regarding director compensation, which is neutral in terms of market impact.

Positives

• Alignment of director interests with shareholders through equity-based compensation.
• Standard annual equity grant indicates normal corporate governance and compensation practices.

Negatives

• None identified.

Risks

• The restricted shares are subject to a vesting period, with full vesting scheduled for May 7, 2027.

Future Outlook

The restricted shares are scheduled to vest on May 7, 2027, contingent upon continued service.

Industry Context

StockSavvy.ai notes that annual equity grants to non-employee directors are a standard industry practice in the healthcare services sector to ensure long-term alignment between board members and shareholders.

Comparison to Industry Standards

• The grant follows standard corporate governance practices for publicly traded companies in the U.S. healthcare sector.
• The use of restricted stock units (RSUs) or restricted shares is consistent with compensation structures at peer companies like HCA Healthcare or Tenet Healthcare.

Corporate Governance

Related Party Transactions

• The director and her husband serve as trustees for The Weis Family Trust, which holds 36,028 shares of the company.

Stakeholder Impact

• Shareholders: Minimal impact; reflects standard director compensation.
• Director: Increased equity stake in the company.

Next Steps

• Vesting of the 7,196 restricted shares on May 7, 2027.

Key Dates

Keywords

Pediatrix Medical Group, MD, Director, Equity Grant, Insider Transaction, Form 4, Incentive Compensation